Onset dynamics of reentrant tachycardia and rate-dependent conduction changes in canine ventricular muscle: effects of Na+ and Ca2+ channel blockade

J Electrocardiol. 2000 Oct;33(4):349-60. doi: 10.1054/jelc.2000.18107.

Abstract

To show that cycle-length (CL) prolongation occurring at the onset of reentrant tachycardias may be associated with an increase in conduction time (CT), and to investigate the involvement of Na+ and Ca2+ channel activity, reentrant activity was induced by programmed stimulation in thin ventricular muscle slices with a central cryothermal lesion, as documented with 7 to 12 bipolar recordings. We studied the course of the CL measured in successive tachycardia beats, as well as the course of conduction times after abrupt transition from a pacing CL of 1,000 to 400 ms (pacing paradigm). The majority of the tachycardias displayed a dynamic behavior in which CL increased progressively, with an exponential rate constant of 37 +/- 35 beats (mean +/- SD), stabilizing at 325 +/- 67 ms after a total increase of 17 +/- 17 ms. In the pacing paradigm, CT was prolonged from 68 +/- 21 ms to 79 +/- 24 ms according to a biphasic course consisting of an abrupt increase in the first response to 400 ms, followed up by an exponential increase, stabilizing with a rate constant of 18 +/- 23 beats. Lidocaine 5 x 10(-5) mol/L induced an increase in steady-state CT, which was not further modified by adding verapamil 10(-5) mol/L. However, verapamil prolonged the rate constant of the exponential course by 60 +/- 40 beats. Thus, the onset dynamics of reentrant tachycardias share common features with the dynamic behavior of CT in the pacing paradigm, in which both Na+ channel activity and Ca2+-modulated cellular coupling appear to be involved.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Arrhythmia Agents / pharmacology*
  • Calcium Channel Blockers / pharmacology*
  • Cardiac Pacing, Artificial
  • Data Interpretation, Statistical
  • Dogs
  • Electrocardiography / methods*
  • Heart Conduction System / drug effects
  • Heart Conduction System / physiopathology*
  • Heart Ventricles / physiopathology*
  • In Vitro Techniques
  • Lidocaine / pharmacology*
  • Sodium Channels / drug effects*
  • Tachycardia, Ventricular / physiopathology*
  • Verapamil / pharmacology*

Substances

  • Anti-Arrhythmia Agents
  • Calcium Channel Blockers
  • Sodium Channels
  • Lidocaine
  • Verapamil